Spark Therapeutics, a spin-out of Children's Hospital of Philadelphia, is developing gene therapy treatments for a rare blinding disorder and haemophilia.

Spin-out Cambridge Semiconductor acquired by Silicon Valley-based electronic components firm Power Integrations.

Mobile game developer Linekong previously $115m in three funding rounds from investors including IDG Capital Partners.

Spark Therapeutics, a drug developer spinout of Children's Hospital of Philadelphia, is set to go public on Nasdaq.

The molecular profiling company, backed by Novo, GlaxoSmithKline and Merck, is seeking to float on Nasdaq.

Reliance Industries bought the diversified media company, granting Nokia a reported exit around 2.4x.

The Kraft-backed neuromuscular treatment developer is seeking $60m, which will be invested in research and marketing.

The insulin pump developer, backed by Novo and Lundbeck, will also seek $17.1m from a concurrent private placement.

Cardiovascular imaging technology developer Infraredx, which is backed by Nipro and Intrepid Maritime, is looking to advance trials for its catheter product.